ENTPD1 and ovarian cancer: In tumors, CD73 and CD39 were found to both be overexpressed and functionally active in producing adenosine in ovarian cancer cells [90], and melanoma cells expressed the enzymes for both the canonical (CD39/CD73) and alternative (CD38/CD203a) pathways for adenosine production [91].